Zhejiang Hisun Pharma. Co., Ltd.
About Zhejiang Hisun Pharma. Co., Ltd.
Categories
-
CN
-
2015On CPHI since
Meet us at
CPHI Japan 2025
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
09 Apr 2025 – 11 Apr 2025
CPHI Frankfurt 2025
Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from Zhejiang Hisun Pharma. Co., Ltd. (41)
-
Product Orlistat
OTC weight-reducing drug , DMF available
-
Product Acarbose
Antidiabetic Agents, DMF approved, CEP approved -
Product Tigecycline
Anti-infective API, DMF available -
Product Meropenem
Anti-infective API, DMF available -
Product Isepamicin Sulfate
Anti-infective API, DMF available -
Product Daptomycin
Anti-infective API, DMF approved -
Product Simvastatin
Cardiovascular API, DMF available, CEP approved -
Product Pravastatin Sodium
Cardiovascular API, DMF available, CEP approved -
Product Lovastatin
Cardiovascular API, DMF available, CEP approved -
Product Atorvastatin Calcium
Cardiovascular API, DMF available, CEP approved -
Product Adenosine
Cardiovascular API, DMF approved, CEP approved -
Product Mitomycin
Oncology API, DMF approved, CEP approved
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance